Integramed America, Inc. (INMD) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $13.97 -0.57%
Revenue Growth %: -1.7%
Financial Fact:
Income tax provision: 865K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: -1.7%
Financial Fact:
Income tax provision: 865K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q2 adjusted EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.05 million versus the consensus estimate of $68.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Rogers Communications (RCI) Tops Q3 EPS by 42c
- Balchem Corp. (BCPC) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
